Outcome following open TAAA repair after TEVAR compared to conventional open type II TAAA repair.

IF 3.4 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE
Jelle Frankort, Andras Keszei, Panagiotis Doukas, Christian Uhl, Michael J Jacobs, Barend M E Mees, Alexander Gombert, Moustafa Elfeky
{"title":"Outcome following open TAAA repair after TEVAR compared to conventional open type II TAAA repair.","authors":"Jelle Frankort, Andras Keszei, Panagiotis Doukas, Christian Uhl, Michael J Jacobs, Barend M E Mees, Alexander Gombert, Moustafa Elfeky","doi":"10.1024/0301-1526/a001247","DOIUrl":null,"url":null,"abstract":"<p><p><b></b> <i>Background:</i> Open thoracoabdominal aortic aneurysm (TAAA) repair for Crawford extent II aneurysms carries substantial risks. This study compares outcomes of open TAAA repair following prior thoracic endovascular aortic repair (TEVAR) with conventional open extent II repair. <i>Patients and methods:</i> A retrospective analysis of 91 patients (2006-2024) divided into prior TEVAR (n=29) and conventional repair Crawford extent II repair without previous TEVAR (n=62). Primary endpoints included mortality and complications; secondary endpoints assessed survival and reinterventions. This study was designed according to STROBE criteria. <i>Results:</i> The prior TEVAR group (n=29) had a mean age of 61.5±10.7 years and 72.4% were male, while the conventional extent II repair group (n=62) had a mean age of 63.2±9.8 years and 69.4% were male. Prior TEVAR patients underwent open repair for extent II (13.8%), III (58.6%), or IV (27.6%) aneurysms. In-hospital mortality was lower in the prior TEVAR group (6.9% vs. 25.8%, p =.07), as were rates of spinal cord ischemia (3.4% vs. 8.1%, p =.55), acute kidney injury (24.1% vs. 35.5%, p =.28), and massive transfusion (24.1% vs. 30.6%, p =.54). Pulmonary complications occurred less frequently after TEVAR (69.0% vs. 82.3%, p =.25). Kaplan-Meier analysis revealed no significant survival difference (log-rank p=.05), with 5-year survival rates of 94% (prior TEVAR) and 61% (conventional). Aortic reintervention rates were also similar (10.5% vs. 18.8%, p=.69). <i>Conclusions:</i> Open TAAA repair following prior TEVAR may offer clinically meaningful advantages over conventional open type II repair with acceptable survival rates; however, these findings should be interpreted cautiously given the study's retrospective design and small sample size. Staged hybrid approach could be a viable strategy for managing complex aortic pathologies.</p>","PeriodicalId":23528,"journal":{"name":"Vasa-european Journal of Vascular Medicine","volume":" ","pages":"114-120"},"PeriodicalIF":3.4000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vasa-european Journal of Vascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1024/0301-1526/a001247","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/24 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Open thoracoabdominal aortic aneurysm (TAAA) repair for Crawford extent II aneurysms carries substantial risks. This study compares outcomes of open TAAA repair following prior thoracic endovascular aortic repair (TEVAR) with conventional open extent II repair. Patients and methods: A retrospective analysis of 91 patients (2006-2024) divided into prior TEVAR (n=29) and conventional repair Crawford extent II repair without previous TEVAR (n=62). Primary endpoints included mortality and complications; secondary endpoints assessed survival and reinterventions. This study was designed according to STROBE criteria. Results: The prior TEVAR group (n=29) had a mean age of 61.5±10.7 years and 72.4% were male, while the conventional extent II repair group (n=62) had a mean age of 63.2±9.8 years and 69.4% were male. Prior TEVAR patients underwent open repair for extent II (13.8%), III (58.6%), or IV (27.6%) aneurysms. In-hospital mortality was lower in the prior TEVAR group (6.9% vs. 25.8%, p =.07), as were rates of spinal cord ischemia (3.4% vs. 8.1%, p =.55), acute kidney injury (24.1% vs. 35.5%, p =.28), and massive transfusion (24.1% vs. 30.6%, p =.54). Pulmonary complications occurred less frequently after TEVAR (69.0% vs. 82.3%, p =.25). Kaplan-Meier analysis revealed no significant survival difference (log-rank p=.05), with 5-year survival rates of 94% (prior TEVAR) and 61% (conventional). Aortic reintervention rates were also similar (10.5% vs. 18.8%, p=.69). Conclusions: Open TAAA repair following prior TEVAR may offer clinically meaningful advantages over conventional open type II repair with acceptable survival rates; however, these findings should be interpreted cautiously given the study's retrospective design and small sample size. Staged hybrid approach could be a viable strategy for managing complex aortic pathologies.

TEVAR术后开放性TAAA修复的结果与传统开放性II型TAAA修复的比较。
背景:开放性胸腹主动脉瘤(TAAA)修复克劳福德II级动脉瘤有很大的风险。本研究比较了先前胸椎血管内主动脉修复(TEVAR)后开放TAAA修复与常规开放II段修复的结果。患者和方法:回顾性分析91例(2006-2024)患者,分为既往TEVAR (n=29)和常规修复(n=62)。主要终点包括死亡率和并发症;次要终点评估生存和再干预。本研究按照STROBE标准设计。结果:既往TEVAR组(n=29)平均年龄61.5±10.7岁,男性占72.4%;常规II级修复组(n=62)平均年龄63.2±9.8岁,男性占69.4%。先前的TEVAR患者接受过II(13.8%)、III(58.6%)或IV(27.6%)动脉瘤的切开修复。先前的TEVAR组住院死亡率较低(6.9%对25.8%,p = 0.07),脊髓缺血发生率较低(3.4%对8.1%,p = 0.55),急性肾损伤发生率较低(24.1%对35.5%,p = 0.28),大量输血发生率较低(24.1%对30.6%,p = 0.54)。TEVAR术后肺部并发症发生率较低(69.0% vs. 82.3%, p = 0.25)。Kaplan-Meier分析显示生存率无显著差异(log-rank p= 0.05), 5年生存率分别为94%(先前TEVAR)和61%(常规)。主动脉再介入率也相似(10.5% vs. 18.8%, p= 0.69)。结论:与传统的开放式II型修复相比,先前TEVAR后的开放式TAAA修复可能具有临床意义的优势,且存活率可接受;然而,考虑到研究的回顾性设计和小样本量,这些发现应该谨慎解释。分阶段混合入路可能是治疗复杂主动脉病变的可行策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.90
自引率
11.10%
发文量
61
审稿时长
1 months
期刊介绍: Vasa is the European journal of vascular medicine. It is the official organ of the German, Swiss, and Slovenian Societies of Angiology. The journal publishes original research articles, case reports and reviews on vascular biology, epidemiology, prevention, diagnosis, medical treatment and interventions for diseases of the arterial circulation, in the field of phlebology and lymphology including the microcirculation, except the cardiac circulation. Vasa combines basic science with clinical medicine making it relevant to all physicians interested in the whole vascular field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书